PATENT CLAIM ANALYSIS

Application Number: 16102368
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["424", "009520"]

Abstract:
The present disclosure relates to a composition of albumin microbubbles to which are bound one or more moieties that exhibit a binding preference for the albumin microbubbles relative to free, native HSA. Production of the albumin microbubble composition and use of the albumin microbubble composition in ultrasound mediated delivery of therapeutic or diagnostic agents is also discussed.

Claim (Index 6):
An ultrasound-based treatment method, comprising:\n introducing an albumin microbubble composition into a patient, wherein the albumin microbubble composition comprises: an albumin shell, a molecule of interest, and a moiety binding the molecule of interest to the albumin shell, wherein the moiety preferentially binds to the albumin shell relative to free, native human serum albumin; and directing ultrasonic energy at an anatomic region of interest to cause cavitation of the albumin microbubbles at the anatomic region of interest.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 96.0
- Lexical Diversity: 1.39535
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14550689', '15219419', '11894821', '10028738', '14129574']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7163998371115763
- 35 USC 102 Novelty (BERT): 0.5540208014074749
- Combined Prediction Score: 0.7001619335411662
- Mean Citation Score: 270.85028
- Max Citation Score: 441.87677
- Similarity Product: 316.310451644618

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test